Biden careful not to play favorites but Pfizer enjoys some 'comparative advantage' in mandate era

The COVID-19 vaccine from Pfizer and BioNTech was the first to reach American arms, and it accounts for over half of the 380 million doses administered in the U.S. so far.

The shot has another advantage as the nation hurtles into a period in which workers must either get vaccinated ...